Literature DB >> 30528327

Females are less sensitive than males to the motivational- and dopamine-suppressing effects of kappa opioid receptor activation.

Sineadh M Conway1, Daniel Puttick2, Shayla Russell2, David Potter2, Mitchell F Roitman3, Elena H Chartoff4.   

Abstract

The neuropeptide dynorphin (DYN) activates kappa opioid receptors (KORs) in the brain to produce depressive-like states and decrease motivation. KOR-mediated suppression of dopamine release in the nucleus accumbens (NAc) is considered one underlying mechanism. We previously showed that, regardless of estrous cycle stage, female rats are less sensitive than males to KOR agonist-mediated decreases in motivation to respond for brain stimulation reward, measured with intracranial self-stimulation (ICSS). However, the explicit roles of KORs, circulating gonadal hormones, and their interaction with dopamine signaling in motivated behavior are not known. As such, we measured the effects of the KOR agonist U50,488 on ICSS stimulation thresholds before and after gonadectomy (or sham surgery). We found that ovariectomized females remained less sensitive than sham or castrated males to KOR-mediated decreases in brain stimulation reward, indicating that circulating gonadal hormones do not play a role. We used qRT-PCR to examine whether sex differences in gene expression in limbic brain regions are associated with behavioral sex differences. We found no sex differences in Pdyn or Oprk1 mRNA in the NAc and ventral tegmental area (VTA), but tyrosine hydroxylase (Th) mRNA was significantly higher in female compared to male VTA. To further explore sex-differences in KOR-mediated suppression of dopamine, we used fast scan cyclic voltammetry (FSCV) and demonstrated that U50,488 was less effective in suppressing evoked NAc dopamine release in females compared to males. These data raise the possibility that females are protected from KOR-mediated decreases in motivation by an increased capacity to produce and release dopamine.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dynorphin; Fast scan cyclic voltammetry; Intracranial self-stimulation; Rat; Tyrosine hydroxylase; U50,488

Mesh:

Substances:

Year:  2018        PMID: 30528327      PMCID: PMC6339824          DOI: 10.1016/j.neuropharm.2018.12.002

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  48 in total

Review 1.  Rapid effects of ovarian hormones in dorsal striatum and nucleus accumbens.

Authors:  Katie E Yoest; Jacqueline A Quigley; Jill B Becker
Journal:  Horm Behav       Date:  2018-04-22       Impact factor: 3.587

2.  Sex differences in the effects of estradiol in the nucleus accumbens and striatum on the response to cocaine: neurochemistry and behavior.

Authors:  Jennifer A Cummings; Lakshmikripa Jagannathan; Lisa R Jackson; Jill B Becker
Journal:  Drug Alcohol Depend       Date:  2013-09-19       Impact factor: 4.492

3.  Direct in vivo monitoring of dopamine released from two striatal compartments in the rat.

Authors:  A G Ewing; J C Bigelow; R M Wightman
Journal:  Science       Date:  1983-07-08       Impact factor: 47.728

4.  Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.

Authors:  Yu-Jun Wang; Khampaseuth Rasakham; Peng Huang; Darina Chudnovskaya; Alan Cowan; Lee-Yuan Liu-Chen
Journal:  J Pharmacol Exp Ther       Date:  2011-08-12       Impact factor: 4.030

5.  Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated.

Authors:  R Bals-Kubik; A Herz; T S Shippenberg
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Dopamine release from pharmacologically distinct storage pools in rat striatum following stimulation at frequency of neuronal bursting.

Authors:  L Yavich; E MacDonald
Journal:  Brain Res       Date:  2000-07-07       Impact factor: 3.252

Review 7.  The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.

Authors:  M R Bruchas; B B Land; C Chavkin
Journal:  Brain Res       Date:  2009-08-28       Impact factor: 3.252

8.  Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens.

Authors:  Jonathan M Ehrich; Paul E M Phillips; Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2014-06-27       Impact factor: 7.853

9.  Extragonadal aromatization increases with time after ovariectomy in rats.

Authors:  Hong Zhao; Zhanzhuang Tian; Junwei Hao; Boying Chen
Journal:  Reprod Biol Endocrinol       Date:  2005-01-21       Impact factor: 5.211

10.  Dopaminergic dynamics underlying sex-specific cocaine reward.

Authors:  Erin S Calipari; Barbara Juarez; Carole Morel; Deena M Walker; Michael E Cahill; Efrain Ribeiro; Ciorana Roman-Ortiz; Charu Ramakrishnan; Karl Deisseroth; Ming-Hu Han; Eric J Nestler
Journal:  Nat Commun       Date:  2017-01-10       Impact factor: 14.919

View more
  14 in total

1.  Kappa opioid receptors in the bed nucleus of the stria terminalis regulate binge-like alcohol consumption in male and female mice.

Authors:  Harold L Haun; William C Griffin; Marcelo F Lopez; Howard C Becker
Journal:  Neuropharmacology       Date:  2020-02-02       Impact factor: 5.250

2.  Sex differences in fear regulation and reward-seeking behaviors in a fear-safety-reward discrimination task.

Authors:  Eliza M Greiner; Iris Müller; Makenzie R Norris; Ka H Ng; Susan Sangha
Journal:  Behav Brain Res       Date:  2019-04-11       Impact factor: 3.332

Review 3.  Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.

Authors:  Elyssa B Margolis; Anushree N Karkhanis
Journal:  Neurochem Int       Date:  2019-07-10       Impact factor: 3.921

4.  Blockade of kappa-opioid receptors amplifies microglia-mediated inflammatory responses.

Authors:  Galen Missig; Emma L Fritsch; Niyati Mehta; Miles E Damon; Erica M Jarrell; Andrew A Bartlett; F Ivy Carroll; William A Carlezon
Journal:  Pharmacol Biochem Behav       Date:  2021-11-23       Impact factor: 3.533

5.  Phasic dopamine responses to a food-predictive cue are suppressed by the glucagon-like peptide-1 receptor agonist Exendin-4.

Authors:  Vaibhav R Konanur; Ted M Hsu; Scott E Kanoski; Matthew R Hayes; Mitchell F Roitman
Journal:  Physiol Behav       Date:  2019-12-09

Review 6.  Sex differences in dopamine release regulation in the striatum.

Authors:  Jennifer E Zachry; Suzanne O Nolan; Lillian J Brady; Shannon J Kelly; Cody A Siciliano; Erin S Calipari
Journal:  Neuropsychopharmacology       Date:  2020-12-14       Impact factor: 7.853

7.  KOR Control over Addiction Processing: An Exploration of the Mesolimbic Dopamine Pathway.

Authors:  Paige M Estave; Mary B Spodnick; Anushree N Karkhanis
Journal:  Handb Exp Pharmacol       Date:  2022

8.  Paradoxical changes in brain reward status during oxycodone self-administration in a novel test of the negative reinforcement hypothesis.

Authors:  Jacques D Nguyen; Yanabel Grant; Michael A Taffe
Journal:  Br J Pharmacol       Date:  2021-06-08       Impact factor: 9.473

9.  Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction.

Authors:  Catherine M Cahill; Lindsay Lueptow; Hannah Kim; Raj Shusharla; Amy Bishop; Christopher J Evans
Journal:  Handb Exp Pharmacol       Date:  2022

10.  Sex differences in kappa opioid receptor antinociception is influenced by the number of X chromosomes in mouse.

Authors:  Anna M W Taylor; Caylin I Chadwick; Sadaf Mehrabani; Haley Hrncir; Arthur P Arnold; Christopher J Evans
Journal:  J Neurosci Res       Date:  2020-07-30       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.